NSAIDs - Pharmacology

1. A 68-year-old female with rheumatoid arthritis and a history of a bleeding peptic ulcer 1 year ago requires an anti-inflammatory agent. Her current medications include methotrexate. Which of the following is the most appropriate management strategy to minimize her risk of a recurrent GI bleed?
   Answer: Prescribe celecoxib and co-administer a proton pump inhibitor. The patient is at high risk for a recurrent GI bleed. The best strategy combines a COX-2 selective inhibitor (celecoxib), which spares the gastroprotective COX-1 enzyme, with a proton pump inhibitor (PPI), which is the most effective agent for preventing NSAID-induced ulcers. This combination offers the lowest risk of GI complications.
2. A 78-year-old male with type 2 diabetes, CKD stage 3 (eGFR 45 mL/min/1.73m²), and heart failure is prescribed indomethacin for an acute gout flare. Which of the following adverse effects is this patient at the highest risk of developing?
   Answer: A hemodynamically-mediated further decrease in glomerular filtration rate. This patient has multiple potent risk factors for NSAID-induced acute kidney injury: advanced age, pre-existing CKD, and heart failure. In these conditions, renal perfusion is critically dependent on prostaglandin-mediated vasodilation of the afferent arteriole. Indomethacin, a potent non-selective NSAID, will inhibit this protective mechanism, leading to a high probability of a hemodynamically-mediated acute decline in GFR.
3. A patient with a history of gastritis asks if switching from their prescribed naproxen to over-the-counter ibuprofen would be safer for their stomach. Which statement provides the most accurate information to this patient?
   Answer: Both naproxen and ibuprofen are non-selective NSAIDs that carry a significant risk of GI toxicity; switching is unlikely to provide a meaningful reduction in risk. This addresses a common patient misconception. Both ibuprofen and naproxen are traditional, non-selective NSAIDs that inhibit both COX-1 and COX-2. While population studies may show slight differences in relative risk, for an individual patient at risk for GI toxicity, both carry a significant risk. Switching between them is not a recognized strategy for meaningfully improving gastric safety. The primary mechanism of injury is systemic prostaglandin inhibition, not just local irritation.
4. A 34-year-old woman at 33 weeks gestation presents with a severe ankle sprain. She has no other medical conditions. Which of the following is the most significant potential fetal risk associated with prescribing a course of oral diclofenac at this stage of pregnancy?
   Answer: Premature closure of the fetal ductus arteriosus. NSAIDs are contraindicated in the third trimester of pregnancy (after 30 weeks gestation). Prostaglandins, particularly PGE2, are responsible for keeping the fetal ductus arteriosus patent. Inhibition of prostaglandin synthesis by an NSAID can lead to its premature constriction or closure in utero, resulting in fetal pulmonary hypertension and right ventricular failure.
5. A 50-year-old patient develops fever, rash, and eosinophilia two weeks after starting a high-dose regimen of diclofenac for back pain. Urinalysis reveals white blood cell casts and eosinophiluria, and serum creatinine is elevated. Which of the following terms best describes this NSAID-induced renal pathology?
   Answer: Acute interstitial nephritis This clinical presentation—fever, rash, eosinophilia, and renal failure with an active urinary sediment (WBC casts, eosinophiluria)—is the classic picture of acute interstitial nephritis (AIN). AIN is a cell-mediated hypersensitivity reaction affecting the renal interstitium and tubules. NSAIDs are a well-known cause of drug-induced AIN.
6. A 55-year-old male taking low-dose aspirin (81 mg daily) for secondary prevention of cardiovascular events is scheduled for an elective cholecystectomy. A colleague suggests switching him to ibuprofen 400 mg daily to manage his arthritis pain, believing it offers sufficient antiplatelet effect until the day before surgery. Why is this suggestion pharmacologically inappropriate?
   Answer: Ibuprofen's reversible COX-1 inhibition can block aspirin's access to its binding site, reducing its irreversible cardioprotective effect. Aspirin acetylates platelet COX-1 irreversibly, providing an antiplatelet effect for the life of the platelet (7-10 days). Ibuprofen is a reversible, competitive inhibitor of COX-1. If ibuprofen is taken before or concurrently with aspirin, it can occupy the active site of the COX-1 enzyme, sterically hindering aspirin from binding and acetylating it. This can reduce or negate aspirin's long-term cardioprotective benefit.
7. Under normal physiologic conditions in a healthy, euvolemic individual, a standard dose of an NSAID has minimal effect on GFR. However, in a patient with decompensated cirrhosis and ascites, the same dose can precipitate acute kidney injury. This difference is primarily because prostaglandins play a critical role in:
   Answer: maintaining afferent arteriolar dilation to preserve renal perfusion in states of high RAAS activation. In states of effective volume depletion such as decompensated cirrhosis, the renin-angiotensin-aldosterone system (RAAS) and sympathetic nervous system are highly activated, causing systemic and renal vasoconstriction to maintain blood pressure. To preserve renal blood flow, the kidneys synthesize vasodilatory prostaglandins (PGE2, PGI2) that dilate the afferent arteriole. NSAIDs block this crucial compensatory mechanism, leading to unopposed afferent vasoconstriction, decreased renal perfusion, and a drop in GFR.
8. A 45-year-old female with a history of chronic rhinosinusitis with nasal polyps and persistent asthma reports severe bronchospasm and urticaria minutes after taking a single dose of aspirin. She presents today with acute musculoskeletal pain. Which of the following medications is absolutely contraindicated in this patient?
   Answer: Ketoprofen This patient's presentation is classic for aspirin-exacerbated respiratory disease (AERD), or Samter's triad. The underlying mechanism involves shunting of arachidonic acid metabolism towards the leukotriene pathway upon COX-1 inhibition. This cross-reactivity applies to aspirin and all other non-selective NSAIDs. Therefore, ketoprofen, a non-selective NSAID, is absolutely contraindicated. Acetaminophen and tramadol are generally safe, and while caution is urged with celecoxib, it is not considered an absolute contraindication.
9. A pharmaceutical company is developing a new NSAID. Preclinical studies show that it has an IC50 for COX-1 of 50 µM and an IC50 for COX-2 of 0.5 µM. Based on this profile, which of the following is most likely to be true regarding the drug's effects at therapeutic concentrations?
   Answer: It will have a lower propensity to cause gastric mucosal damage compared to a non-selective NSAID. The ratio of IC50 (COX-1/COX-2) is 50/0.5 = 100, indicating that the drug is 100 times more potent at inhibiting COX-2 than COX-1. This profile is characteristic of a selective COX-2 inhibitor. By preferentially inhibiting COX-2 and sparing COX-1 at therapeutic doses, the drug will preserve the synthesis of COX-1-derived protective prostaglandins in the gastric mucosa, leading to a lower risk of GI toxicity compared to non-selective agents like ibuprofen or naproxen.
10. A patient taking daily low-dose aspirin for cardioprotection requires intermittent analgesia for headaches. They are advised to avoid concurrent ibuprofen use. What is the fundamental pharmacodynamic difference between aspirin and ibuprofen that underlies this recommendation?
    Answer: Aspirin causes irreversible acetylation of platelet COX-1, while ibuprofen is a reversible, competitive inhibitor. The key difference is the nature of COX-1 inhibition. Aspirin forms a covalent bond, irreversibly acetylating the serine residue in the active site of platelet COX-1. This effect lasts for the life of the platelet (7-10 days). Ibuprofen binds reversibly and competitively to the same site. If ibuprofen is present, it can block aspirin's access, preventing the irreversible inhibition required for sustained cardioprotection.
11. An 8-year-old child is recovering from an influenza infection. The parents administered an over-the-counter medication for fever and aches. Several days later, the child develops persistent vomiting, lethargy, and confusion. Laboratory tests show elevated aminotransferases, hyperammonemia, and a prolonged prothrombin time. The use of which medication is most likely associated with this clinical presentation?
    Answer: Aspirin This clinical vignette describes Reye's syndrome, a rare but serious condition characterized by acute encephalopathy and fatty liver failure. There is a strong epidemiological association between the use of aspirin (a salicylate) for fever in children and adolescents during a viral illness (especially influenza or varicella) and the development of Reye's syndrome. For this reason, aspirin is contraindicated in this population.
12. A 40-year-old male undergoes orthopedic surgery and is prescribed intravenous ketorolac for post-operative pain. His pre-operative serum creatinine was 1.0 mg/dL. On post-op day 4, his creatinine is 1.8 mg/dL and his urine output is low. The patient has received ketorolac every 6 hours since surgery. What is the most likely contributing factor to his renal dysfunction?
    Answer: Exceeding the recommended maximum duration of therapy, which is limited due to high risk of severe adverse effects. Ketorolac carries a black box warning for significant renal and GI toxicity. Due to these risks, the total combined duration of therapy (parenteral and oral) is strictly limited to a maximum of 5 days. The post-operative state is already a risk factor for renal hypoperfusion. Using ketorolac for 4 days in this setting makes dose- and duration-dependent toxicity the most probable cause of his acute kidney injury.
13. A 70-year-old male is on stable, long-term warfarin therapy for atrial fibrillation, with a target INR of 2.0-3.0. He starts taking over-the-counter naproxen for arthritis pain. Which of the following represents the most significant combined risk of this drug combination?
    Answer: A pharmacodynamic interaction significantly increasing the risk of major gastrointestinal bleeding. The most critical risk is a pharmacodynamic interaction. NSAIDs cause direct gastric mucosal injury and inhibit platelet aggregation (a COX-1 mediated effect). Warfarin inhibits the synthesis of vitamin K-dependent clotting factors. The combination of impaired platelet plug formation, compromised mucosal integrity, and impaired coagulation cascade creates a synergistic and extremely high risk of severe gastrointestinal bleeding, even if the INR remains in the therapeutic range.
14. A 62-year-old male with a history of myocardial infarction 2 years ago has severe osteoarthritis of the knees. His physician is considering prescribing celecoxib to minimize GI side effects. Which statement best explains the primary cardiovascular concern with using a selective COX-2 inhibitor in this patient?
    Answer: Selective inhibition of COX-2 decreases prostacyclin (PGI2) production without affecting COX-1-mediated thromboxane A2 (TXA2) synthesis, creating a prothrombotic state. The primary concern is the creation of a prothrombotic state. Platelets produce thromboxane A2 (TXA2) via COX-1, which promotes platelet aggregation and vasoconstriction. Vascular endothelial cells produce prostacyclin (PGI2) via COX-2, which inhibits platelet aggregation and causes vasodilation. By selectively inhibiting COX-2, celecoxib reduces PGI2, leaving the prothrombotic effects of TXA2 unopposed, thereby increasing the risk of cardiovascular events like MI and stroke.
15. A 75-year-old male with stable congestive heart failure (ejection fraction 30%) and hypertension is managed with lisinopril and furosemide. He is started on ibuprofen 600 mg three times daily for osteoarthritis pain. One week later, his serum creatinine increases from 1.2 mg/dL to 2.5 mg/dL. What is the most likely mechanism for this acute kidney injury?
    Answer: Inhibition of prostaglandin-mediated afferent arteriolar vasodilation. In states of decreased effective circulating volume like heart failure, renal blood flow is highly dependent on prostaglandins (PGE2, PGI2) to vasodilate the afferent arteriole. NSAIDs inhibit prostaglandin synthesis, leading to unopposed vasoconstriction of the afferent arteriole, a decrease in glomerular filtration pressure, and subsequent acute kidney injury. This risk is magnified by concurrent ACE inhibitor use, which dilates the efferent arteriole.
16. A 70-year-old female presents with severe knee pain from osteoarthritis. Her medical history is significant for a coronary artery stent placed 3 years ago (on aspirin 81 mg and clopidogrel), hypertension (on lisinopril), and GERD (on omeprazole). She has a serum creatinine of 1.4 mg/dL. Which of the following is the most significant contraindication or risk associated with initiating a traditional, non-selective NSAID like diclofenac in this patient?
    Answer: The extremely high risk of a major GI bleed due to the combined use of dual antiplatelet therapy and an NSAID. While all the listed options are valid concerns, the most immediate and life-threatening risk in this patient is a major gastrointestinal bleed. She is on dual antiplatelet therapy (aspirin and clopidogrel), which already significantly increases bleeding risk. Adding an NSAID—which is independently ulcerogenic and also inhibits platelet function—creates a 'triple whammy' that elevates the risk of a severe GI bleed to a prohibitive level. This combination is relatively contraindicated.
17. A 66-year-old female with hypertension, well-controlled on ramipril and hydrochlorothiazide, begins taking over-the-counter naproxen for knee pain. During a follow-up visit one month later, her blood pressure is elevated from her baseline of 125/75 mmHg to 150/90 mmHg. The addition of naproxen is most likely antagonizing the effects of her antihypertensive medications by which mechanism?
    Answer: Inhibiting the synthesis of renal prostaglandins, leading to increased sodium and water reabsorption. Renal prostaglandins have a natriuretic and diuretic effect, contributing to sodium and water balance. By inhibiting prostaglandin synthesis, NSAIDs promote sodium and water retention. This effect counteracts the therapeutic actions of many antihypertensive agents, particularly diuretics (like hydrochlorothiazide) and ACE inhibitors (like ramipril), leading to an increase in blood pressure.
18. A 72-year-old male with hypertension treated with losartan is given celecoxib for osteoarthritis. A routine metabolic panel one month later shows his serum potassium has increased from 4.2 mEq/L to 5.6 mEq/L. The development of hyperkalemia in this setting is best explained by NSAID-induced inhibition of:
    Answer: prostaglandin-mediated renin release, leading to hypoaldosteronism. NSAIDs can cause hyperkalemia by inducing a state of hyporeninemic hypoaldosteronism. Prostaglandins stimulate renin release from the juxtaglomerular apparatus. By inhibiting prostaglandins, NSAIDs decrease renin, which leads to decreased angiotensin II and subsequently decreased aldosterone production. Reduced aldosterone impairs potassium excretion in the distal nephron. This effect is compounded by the concurrent use of an ARB (losartan), which also impairs the RAAS system and increases potassium.
19. A patient with chronic osteoarthritis is being counseled on strategies to reduce the gastrointestinal toxicity of long-term NSAID therapy. Which statement accurately describes a physiological mechanism relevant to this counseling?
    Answer: Prostaglandin E2 (PGE2), synthesized via COX-1, is a primary mediator of gastric mucosal defense by stimulating mucus and bicarbonate secretion. The gastroprotective effects of prostaglandins are primarily mediated by the COX-1 isoform. Prostaglandin E2 (PGE2) and prostacyclin (PGI2) increase the secretion of protective mucus and bicarbonate, increase mucosal blood flow, and inhibit gastric acid secretion. Inhibition of COX-1 by non-selective NSAIDs removes these protective mechanisms, leading to GI toxicity.

Start this quiz